AR040121A1 - Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer - Google Patents

Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer

Info

Publication number
AR040121A1
AR040121A1 ARP030101849A ARP030101849A AR040121A1 AR 040121 A1 AR040121 A1 AR 040121A1 AR P030101849 A ARP030101849 A AR P030101849A AR P030101849 A ARP030101849 A AR P030101849A AR 040121 A1 AR040121 A1 AR 040121A1
Authority
AR
Argentina
Prior art keywords
inhibitors
acetilcoline
esterase
alzheimer
disease
Prior art date
Application number
ARP030101849A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28051666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR040121(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR040121A1 publication Critical patent/AR040121A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP030101849A 2002-05-31 2003-05-27 Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer AR040121A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200844 2002-05-31

Publications (1)

Publication Number Publication Date
AR040121A1 true AR040121A1 (es) 2005-03-16

Family

ID=28051666

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101849A AR040121A1 (es) 2002-05-31 2003-05-27 Una combinacion de antagonista de nmda e inhibidores de la acetilcolina esterasa para el tratamiento de la enfermedad de alzheimer

Country Status (9)

Country Link
KR (1) KR101016927B1 (is)
CN (1) CN1655793A (is)
AR (1) AR040121A1 (is)
CA (1) CA2426492C (is)
EA (1) EA007632B1 (is)
IS (1) IS7558A (is)
PE (1) PE20040623A1 (is)
UA (1) UA82480C2 (is)
ZA (1) ZA200409147B (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA107653U (uk) 2012-10-01 2016-06-24 Общєство С Огранічєнной Отвєтствєнностью "Валєнта-Інтєллєкт" Композиція лікарських засобів для лікування та профілактики поведінкових, психічних та когнітивних розладів
CN105294450B (zh) * 2014-05-29 2024-05-17 广州喜鹊医药有限公司 具有神经保护作用的金刚烷胺硝酸酯化合物及其制备和医药应用
WO2018062941A1 (ko) * 2016-09-30 2018-04-05 주식회사 바이오파마티스 도네페질 또는 그의 약학적으로 허용 가능한 염 및 메만틴 또는 그의 약학적으로 허용 가능한 염을 함유하는 치매 및 인지기능 장애 예방 또는 치료용 약학 조성물 및 이의 제조방법
KR20210072569A (ko) 2019-12-09 2021-06-17 주식회사 종근당 도네페질 및 메만틴을 포함하는 복합 제제

Also Published As

Publication number Publication date
CN1655793A (zh) 2005-08-17
UA82480C2 (uk) 2008-04-25
IS7558A (is) 2004-11-26
ZA200409147B (en) 2006-06-28
EA007632B1 (ru) 2006-12-29
KR20050024296A (ko) 2005-03-10
CA2426492A1 (en) 2003-09-16
EA200401617A1 (ru) 2005-06-30
KR101016927B1 (ko) 2011-02-28
PE20040623A1 (es) 2004-09-11
CA2426492C (en) 2006-10-03

Similar Documents

Publication Publication Date Title
LU92853I2 (fr) Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégée par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine et l'emtricitabine
ECSP066313A (es) Derivados de la piridazina y su uso como agentes terapéuticos
ECSP066315A (es) Derivados de la piridazina y su uso como agentes terapéuticos
DK1509232T3 (da) Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom
DE60330187D1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
ES2193391T3 (es) Antagonistas muscarinicos.
BG66085B1 (bg) Фенилаланинови производни
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
PA8493701A1 (es) Compuestos para tratar la obesidad
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
CO5570667A2 (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades
CO5630034A2 (es) Procedimiento y composiciones farmaceuticas para tratar aterosclerosis, dislipidemias y afecciones relacionadas
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
UY26839A1 (es) Productos de derivados de la 4 - fenil - piridina
DE69715865T2 (de) Muscarin-antagonisten
AR034362A1 (es) Compuestos analgesicos de liberacion prolongada
AR021844A1 (es) Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion
AR037930A1 (es) Formulaciones de acitromicina directamente compresibles
EA200800880A1 (ru) Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
NI200200095A (es) "composiciones farmacéuticas de amlodipina y atorvastatina"
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
EA200200132A1 (ru) СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister

Legal Events

Date Code Title Description
FB Suspension of granting procedure